A study by Etzerodt et al. showed that lipid nanoparticles loaded with doxorubicin and conjugated with antibodies against CD163 effectively eliminated the CD163+ TAM population within the TME in melanoma models YUMM1.7. The gene discussed is CD163; the disease is melanoma.